Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker PHIO
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Heights Capital Management, Inc. | 1.19M | 9.9% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | CVI Investments, Inc. | 1.19M | 9.9% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Intracoastal Capital LLC | 1.14M | 9.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Daniel B. Asher | 1.14M | 9.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Mitchell P. Kopin | 1.14M | 9.1% | SCHEDULE 13G/A ↗ |
| Dec 11, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Orca Capital AG | 538,707 | 4.9% | SCHEDULE 13G/A ↗ |
| Nov 24, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Orca Capital AG | 700,421 | 6.5% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Orca Capital AG | 409,261 | 4.9% | SCHEDULE 13G/A ↗ |
| Nov 10, 2025 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Heights Capital Management, Inc. | 733,344 | 9.9% | SCHEDULE 13G ↗ |
| Nov 10, 2025 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | CVI Investments, Inc. | 733,344 | 9.9% | SCHEDULE 13G ↗ |
| Nov 7, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Intracoastal Capital LLC | 430,000 | 7.0% | SCHEDULE 13G/A ↗ |
| Nov 7, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Daniel B. Asher | 430,000 | 7.0% | SCHEDULE 13G/A ↗ |
| Nov 7, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Mitchell P. Kopin | 430,000 | 7.0% | SCHEDULE 13G/A ↗ |
| Nov 6, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Orca Capital AG | 800,000 | 9.8% | SCHEDULE 13G/A ↗ |
| Aug 7, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Orca Capital AG | 280,642 | 4.9% | SCHEDULE 13G/A ↗ |
| Feb 7, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | Heights Capital Management, Inc. | 90,988 | 4.9% | SCHEDULE 13G/A ↗ |
| Feb 7, 2025 | SCHEDULE 13G/A (amended) | PHIO Phio Pharmaceuticals Corp. | CVI Investments, Inc. | 90,988 | 4.9% | SCHEDULE 13G/A ↗ |
| Jan 23, 2025 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Orca Capital AG | 514,965 | 9.9% | SCHEDULE 13G ↗ |
| Jan 17, 2025 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Intracoastal Capital LLC | 530,171 | 10.0% | SCHEDULE 13G ↗ |
| Jan 17, 2025 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Daniel B. Asher | 530,171 | 10.0% | SCHEDULE 13G ↗ |
| Jan 17, 2025 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Mitchell P. Kopin | 530,171 | 10.0% | SCHEDULE 13G ↗ |
| Dec 27, 2024 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Intracoastal Capital LLC | 90,987 | 5.0% | SCHEDULE 13G ↗ |
| Dec 27, 2024 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Daniel B. Asher | 90,987 | 5.0% | SCHEDULE 13G ↗ |
| Dec 27, 2024 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Mitchell P. Kopin | 90,987 | 5.0% | SCHEDULE 13G ↗ |
| Dec 26, 2024 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | Heights Capital Management, Inc. | 109,298 | 7.3% | SCHEDULE 13G ↗ |
| Dec 26, 2024 | SCHEDULE 13G | PHIO Phio Pharmaceuticals Corp. | CVI Investments, Inc. | 109,298 | 7.3% | SCHEDULE 13G ↗ |
26 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances